EUVIMEDEUVIMED entdecken
Crossref

Determination of five mTOR inhibitors in human plasma for hepatocellular carcinoma treatment using QuEChERS-UHPLC-MS/MS

Ting Wang, Chengcheng Jin, Wen Jiang, Tingting Zhao, Yanmei Xu, Hui Li

Journal of Pharmaceutical and Biomedical Analysis · 2023

DOI: 10.1016/j.jpba.2023.115652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023. Verfasst von Ting Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MTOR Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A fast and reliable QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) method for pre-processing combined with Ultra - high performance liquid chromatography - tandem mass spectrometry (UHPLC-MS/MS) was established for the analysis of five mammalian rapamycin target protein (mTOR) inhibitors (vistusertib, AZD8055, pictilisib, everolimus, temsirolimus)in human plasma. Extraction was achieved by addition of acetonitrile to the sample followed by anhydrous magnesium sulfate and 30 mg C18 for salting out and purification, respectively. MTOR inhibitors were detected using selective response monitoring (SRM) under positive ion electrospray mode. Vistusertib, AZD8055 and pictilisib showed good linearity with a range of 1-80 ng/ml, Additionally, the concentration of everolimus and temsirolimus was 2.5-200 ng/ml and10-800 ng/ml, respectively. The linear correlation coefficient (R2) of each analysis was ≥ 0.9950. The limit of detection (LOD) and Limit of Quantitation (LOQ) were 0.015-0.75 ng/ml and 1-10 ng/ml, respectively. This method showed a high accuracy with high recovery rate and excellent stability. This method is fast, accurate and reliable, suitable for quantitative detection of mTOR inhibitors in human plasma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMTOR InhibitorsAnimalsHumansChromatography, High Pressure LiquidEverolimusTandem Mass SpectrometryIndazolesSulfonamidesSirolimusBenzamidesMorpholinesPyrimidines

Stichwörter der Autor:innen

Human plasmaMammalian target of rapamycin inhibitorsQuEChERSUHPLC-MS/MS

Substanzen

EverolimusMTOR Inhibitors2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidineIndazolesSulfonamidestemsirolimusSirolimusvistusertibBenzamidesMorpholines

Autor:innen und Institutionen

  • College of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, China.
  • College of Pharmacy, Hebei Medical University, Shijiazhuang 050000, China.
  • Hebei Institute of Drug and Medical Device Inspection, Shijiazhuang, China.
  • Hebei Institute of Drug and Medical Device Inspection, Shijiazhuang, China. Electronic address: lihui7171@163.com.

Förderung

  • Natural Science Foundation of Hebei Province

Zitieren

APA

Wang, T., Jin, C., Jiang, W., Zhao, T., Xu, Y., & Li, H. (2023). Determination of five mTOR inhibitors in human plasma for hepatocellular carcinoma treatment using QuEChERS-UHPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2023.115652

Vancouver

Wang T, Jin C, Jiang W, Zhao T, Xu Y, Li H. Determination of five mTOR inhibitors in human plasma for hepatocellular carcinoma treatment using QuEChERS-UHPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 2023. doi:10.1016/j.jpba.2023.115652

BibTeX
@article{Wang2023,
  author = {Wang, Ting and Jin, Chengcheng and Jiang, Wen and Zhao, Tingting and Xu, Yanmei and Li, Hui},
  title = {Determination of five mTOR inhibitors in human plasma for hepatocellular carcinoma treatment using QuEChERS-UHPLC-MS/MS},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2023},
  doi = {10.1016/j.jpba.2023.115652}
}
Kostenlos starten →